Company / Revenue per Share
Omnicell Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$25.55
FY2025
5-year range
$20.20 / $25.64
FY2021-FY2025
Trend
+4.6%
vs FY2024
Sector context
#71 of 153
Health Care
What the data says
At $25.55, Omnicell's revenue per share ranks #71 of 153 in the Health Care sector. Revenue per Share has fluctuated over the past 10 years, ranging from $8.18 in FY2016 to $25.64 in FY2023.
Based on SEC 10-K filings.
25.55 in FY2025 with a 5-year CAGR of +6.5%.
Remained stable around $25.55 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +8.1%
- 5-Year CAGR
- +6.5%
- 10-Year CAGR
- -
Sector benchmark
#71 of 153 in Health CareTop 46% of 153This company $25.55 Sector average $123.62
▼
-79.3% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 4.6% year-over-year.
- Ranks #71 out of 153 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2023.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $25.55 | +4.6% |
| FY2024 | $24.42 | -4.7% |
| FY2023 | $25.64 | +26.9% |
| FY2022 | $20.20 | -3.7% |
| FY2021 | $20.97 | +12.2% |
| FY2020 | $18.69 | +5.8% |
| FY2019 | $17.67 | -13.7% |
| FY2018 | $20.49 | +5.3% |
| FY2017 | $19.46 | +137.8% |
| FY2016 | $8.18 | -39.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026